博碩士論文 943204026 詳細資訊




以作者查詢圖書館館藏 以作者查詢臺灣博碩士 以作者查詢全國書目 勘誤回報 、線上人數:34 、訪客IP:18.119.158.127
姓名 黃崇凱(Chung-Kai Huang)  查詢紙本館藏   畢業系所 化學工程與材料工程學系
論文名稱 探討pH值對Agaricus blazei 液態發酵生產一次及二次代謝產物之影響
(The influence of pH on production of first andsecondary metabolites formation by Agaricus blazeiin submerged culture)
相關論文
★ 探討菌體形態對於裂褶菌多醣體之影響★ 探討不同培養方式對猴頭菇抗氧化與抗腫瘤性質的影響
★ 探討不同培養溫度Aspergillus niger 對丹參之機能性影響★ 光合菌在光生物反應器產氫之研究
★ 探討培養溫度對巴西蘑菇液態醱酵之影響★ 利用批式液態培養來探討檸檬酸對裂褶菌生長及其多醣體生成影響之研究
★ 探討不同培養基組成對光合菌Rhodobacter sphaeroides生產Coenzyme Q10之研究★ 利用混合特定菌種生產氫氣之研究
★ 探討氧化還原電位作為Clostridium butyricum連續產氫之研究★ 探討培養基之pH值與Xanthan gum的添加對巴西蘑菇多醣體生產之影響
★ 探討麩胺酸的添加和供氧量對液態發酵生產裂褶菌多醣體之研究★ 探討以兩水相系統提昇Clostridium butyricum產氫之研究
★ 探討通氣量對於樟芝醱酵生產生物鹼之影響★ 探討深層發酵中環境因子對巴西洋菇生產多醣之影響
★ 探討通氣量對於樟芝發酵生產與純化脂解酵素之研究★ 探討以活性碳吸附酸來提昇Clostridium butyricum產氫之研究
檔案 [Endnote RIS 格式]    [Bibtex 格式]    [相關文章]   [文章引用]   [完整記錄]   [館藏目錄]   [檢視]  [下載]
  1. 本電子論文使用權限為同意立即開放。
  2. 已達開放權限電子全文僅授權使用者為學術研究之目的,進行個人非營利性質之檢索、閱讀、列印。
  3. 請遵守中華民國著作權法之相關規定,切勿任意重製、散佈、改作、轉貼、播送,以免觸法。

摘要(中) Agaricus blazei原產於巴西,為一種食藥用菇,近年來被廣泛地做研究,包括其代謝產物的生物活性等。
隨著A. blazei的療效及生物活性一一被探討出來,快速且大量的提升發酵的產量以及產率也隨之來的重要,隨著各產物的特性不同,各產物的生產條件也不同,本研究為了增加A. blazei液態培養之一次代謝產物粗多醣、麥角固醇和二次代謝產物Blazeispirol A的產量以及探討各產物間的相互關係,藉由改變環境因子pH值來探討,分別討論搖瓶實驗之不同起始培養基pH值為4、5、6、7及發酵槽實驗之控制發酵全程培養基pH值為4、5、6、7四組實驗,在搖瓶及發酵槽實驗中可以得到一致的趨勢,發酵槽實驗中結果發現隨著pH值的提高對粗多醣的產量有著隨之增加的趨勢,從pH值為4時的0.42g/L到pH值=6時有最大的粗多醣產量為0.53g/L;而在pH值為7時粗多醣產量又降為0.41g/L。對麥角固醇而言,則是隨著pH值下降而產量隨之增加。在pH值為7時,麥角固醇的產量為29.45mg/L,隨著pH值下降到pH值為4時有最大產量為43mg/L。但對於二次代謝產物Blazeispirol A而言,卻是隨著pH值的上升而有上升的趨勢,
在pH值為4時有最低產量為0.61mg/L,隨著pH值上升到7時達到了最大產量16.80mg/L,這意味著雖然在低pH值下有利於生產麥角固醇但卻不利於轉換成其它衍生物,如Blazeispirol A。
另外也探討發酵過程全程控制pH值為7以及只控發酵的起始pH值為7之試驗,研究發現在全程控制與不控發酵過程pH值的試驗中,胞外多醣產量分別為0.41以及0.31g/L;而麥角固醇產量則為29.45以及28.33mg/L;至於Blazeispirol A則是為16.80以及12.69mg/L,此外在發酵過程pH值控制為7時發酵所需時間為9天,而只控發酵起始pH值則需為12天,綜合上述無論在產量及產率而言皆是以全程控制發酵過程pH為7之試驗結果較佳,故發酵過程控制pH值是有其必要性的。
利用本研究可以了解培養基的pH值對於A. blazei液態發酵生產多醣、麥角固醇、Blazeispirol A等產物之影響,以提供日後大量生產所需要的產物時之參考。
摘要(英) Higher fungi are abundant sources of a wide range of useful natural products and new products with interesting biological activities . Agaricusl blazei Murill has been traditionally used as a health food source in Brazil for the prevention of cancer, diabetes, hyperlipidaemia, arteriosclerosis and chronic hepatitis.
The effects of the controlled and uncontrolled pH conditions, as well as of the value of initial pH=7 and controlled pH=7, on production of the valuable bioactive metabolites by A. blazei were investigated in a stirred tank fermenter. The experimental result shows, controlled pH operation was more favourable than the uncontrolled pH operations.
The effects of controlled culture pH ranging from pH 4.0 to 7.0 on cell growth, exopolysaccharide biosynthesis, relationship between ergosterol, and blazeispirol A biosynthesis of A. blazei were examined both in shake flask culture and in a stirred tank fermenter. While the set point of the culture pH during fermentation was controlled from 4.0 to 7.0, the specific growth rate (μ) increased monotonically, and the cell production rate had the same trend; Higher the pH control from 4.0 to 6.0 gradually led to a higher production of production of Polysaccharides. At lower the pH control (pH = 4) was optimum for ergosterol production; however, At higher the pH control (pH = 7) was optimum for blazeispirol A generation.
The work is useful for further optimization of this fungal fermentation process highly efficient production of the valuable bioactive metabolites on a bioreactor scale.
關鍵字(中) ★ 巴西洋菇
★ 發酵
★ 代謝產物
關鍵字(英) ★ pH
★ Agaricus blazei
★ secondary metabolite
論文目次 目錄...................................................Ⅰ
圖索引.................................................VI
表索引.................................................VIII
第一章 緒論.............................................1
1.1研究動機.............................................1
1.2研究目的.............................................2
第二章 文獻回顧.........................................3
2.1大型真菌類之生理活性.................................3
2.2 A. blazei的介紹.....................................5
2.2.1 A. blazei之發現與由來.............................5
2.2.2 A. blazei的型態特徵及分類.........................6
2.2.3 A. blazei之化學組成...............................7
2.2.4 A. blazei的生理活性...............................9
2.2.5 A. blazei的安全性.................................11
2.3菇類活性成份探討.....................................11
2.3.1菇類多醣的介紹.....................................11
2.3.1.1 A. blazei之多醣體...............................15
2.3.2菇類麥角固醇的介紹.................................18
2.3.2.1 A. blazei之麥角固醇.............................20
2.3.3 A. blazei中所含活性成份blazeispirol A的探討.......21
2.4 深層液態發酵培養....................................25
2.5 影響發酵的物理化學等環境生長因子....................25
2.5.1 培養基組成........................................25
2.5.1.1 碳源............................................25
2.5.1.2 氮源............................................26
2.5.1.3 碳氮比..........................................26
2.5.1.4 無機鹽類........................................26
2.5.2 攪拌速率..........................................27
2.5.3 pH值..............................................27
2.5.4 溶氧值(DO值)......................................29
2.5.5 溫度..............................................30
2.5.6 接種量............................................31
2.5.7發酵槽的形式.......................................31
2.6 發酵動態行為的數學模式..............................32
2.6.1 與生長有關的產物(growth-associated product).......32
2.6.2 與生長無關的產物(nongrowth-associated product)....33
2.6.3 混合生長相關的產物(mixed-growth-associated product)................................................33
第三章 材料與方法.......................................34
3.1 實驗材料............................................34
3.1.1 實驗菌株.........................................34
3.1.2 實驗藥品.........................................34
3.1.3 實驗儀器及其他設備................................35
3.1.4 實驗裝置..........................................37
3.2 實驗方法............................................38
3.2.1 菌株保存..........................................38
3.2.2 培養基組成........................................38
3.2.3 操作條件..........................................40
3.2.4 分析方法..........................................41
3.2.4.1 發酵液處理流程...............................41
3.2.4.2 菌重分析.....................................42
3.2.4.3 葡萄糖殘醣分析...............................42
3.2.4.4 多醣體分析...................................44
3.2.4.4.1 粗多醣之分離............................44
3.2.4.4.2 酚-硫酸呈色法分析(總多醣)...............44
3.2.4.5 麥角固醇之分析...............................45
3.2.4.5.1 麥角固醇萃取..................................45
3.2.4.5.1 麥角固醇含量分析..............................46
3.2.4.6 Blazeispirol A 之分析........................47
3.2.4.6.1 Blazeispirol A萃取............................47
3.2.4.6.2 Blazeispirol A含量分析........................47
第四章 實驗結果與討論...................................50
4.1 搖瓶培養實驗........................................50
4.1.1 搖瓶實驗之控不同起始pH值對A. blazei生長的影響....50
4.2 發酵槽培養實驗......................................56
4.2.1 發酵槽實驗之pH值(controlled)對A. blazei生長的影響
........................................................57
4.2.1.1 發酵動力曲線的比較..............................57
4.2.1.2 pH值對於菌體生長型態的影響......................60
4.2.1.3 pH值對於發酵時間的影響..........................64
4.2.1.4 pH值對於菌體生長的影響..........................64
4.2.1.5 pH值對於產物粗多醣的影響........................66
4.2.1.6 pH值對於產物麥角固醇的影響......................68
4.2.1.7 pH值對於產物Blazeispirol A的影響................69
4.2.2 發酵槽實驗之發酵過程控pH值(controlled-pH)及不控pH值 (uncontrolled-pH)對A. blazei生長之比較..................75
第五章 結論.............................................82
參考文獻................................................85
參考文獻 水野 卓、川合正允,1997,“菇類的化學‧生化學”,賴慶亮譯,國立編譯館。
周伯甫,2001,“探討菌體形態對於裂褶菌多醣體生產之影響”,國立中央大學化學工程所,碩士論文。
劉景仁,2006,“探討誘發劑及兩階段培養對樟芝深層發酵三萜類及抗癌作用之影響”,國立臺灣大學食品科技研究所,碩士論文。
王波、鮮靈,2001,“姬松茸栽培技術”,金盾出版社,181頁。
江枝和、朱丹、楊佩玉,1999, “姬松茸的栽培技術”,食用菌學報,6:33-38。
黃賜源,1996,”靈芝液態培養及氣舉式生化反應器應用之研究”,私立東海大學化學工程研究所,碩士論文。
江枝和、朱丹、楊玉佩,1996, “姬松茸生物特性研究”,食用菌學報, 3:5-12。
林錫杰、王伯徹, 2001, “菇類之藥效功用及其生產研究”,食品工業,34:18-29。
李邦敏,2002, “抗癌新希望-巴西蘑菇”, 宇河出版社,203頁。
岩出菌學研究所, 2005,“姬松茸(岩出101株)的真面目”,廖梅譯,青春出版社。
蔡漢霓,2005,“巴西蘑菇萃取物抗氧活性之研究”,國立成功大學醫學檢驗生物技術研究所,碩士論文。
蔡惠利,2004,“巴西蘑菇茶樹菇牛肝菌和雞腿菇之呈味與抗氧化性質”,國立中興大學食品科學系,碩士論文。
Arinaga S., Karimine N., Takamuku K., Nanbara S., Nagamatsu M., Ueo H., Akiyoshi T. (1992) Enhanced production of interleukin-1 and tumor necrosis factor by peripherai monocytes after lentinan administration in patients with gastric carcinoma. Int. J. Immunopharmac. 14:43-47.
Akiyama T., Shibuya N., Hrmova M., Fincher G. B. (1997) Purification and characterization of a β-(1-3)-D-glucan endohydrolase from rice (Oryza sativa) bran. Carbohy. Res. 297:365-374.
Ashida H., Hashimoto T., Nonaka Y., Minato K. I., Kawakami S., Mizuno M., Fukuda I., Kanazawa K. (2002) Suppressive effect of polysaccharides from the edible and medicinal mushrooms, Lentinus edodes and Agaricus blazei, on the expression of cytochrome P450s in mice. Biosci. Biotechnol. Biochem. 66:1610-1614.
Brockmann B., Smit R., Tudzynski P. (1992) Characterization of an extracellular β-1,3-glucanase of Claviceps purpurea. Physiological and Molecular Plant Pathology. 40:191-201.
Cai Y. J., Buswell J. A. and Chang S. T. (1998) β-Glucosidase components of the cellulolytic system of the edible straw mushroom, Volvariella volvacea. Enzyme and Microbial Technology. 22:122-129.
Candan T., Millie U., Maxwell W. A., Tajalli K. (1998) Effect of pH on physiology of Metarhizium anisopliae for production of swainsonine. FEMS Microbiology Letters. 168: 17-23.
Carlsen M., Spohr A. B., Nielsen J., Villadsen J. (1995) Morphology and physiology of an α-amylase producing strain of Aspergillus oryzae during batch cultivations. Biotechnol Bioeng. 49: 266-76
Ellertsen L. K., Hetland G., Johnson E., Grinde B. (2006) Effect of a medicinal extract from Agaricus blazei Murill on gene expression in a human monocyte cell line as examined by microarrays and immuno assays. Int Immunopharmacol. 6(2):133-143.
Fujimiya Y., Suzuki Y., Kobori H., Oshiman K. I., Moriguchi K., Nakashima H., Matumoto Y., Takahara S., Ebina T., Katakura R. (1998) Selective tumoricidal effect of soluble proteoglucan extracted from the basidiomycete, Agaricus blazei Murill, mediated via natural killer cell activation and apotosis. Cancer Immunol. Immunother. 46:147-159.
Dirk W. B., Jutta A. R., Matthias A.( 2001) Parallel substrate feeding and pH control in shaking flasks. Biochemical Engineering Journal. 7: 163-170
Fang J., Dong Q., Yao J., Yang X. (2002) Structural characterization of a water-soluble β-D-glucan from fruiting bodies of Agaricus blazei Murill. Carbohydr. Res. 337:1417-1421.
Forage R. G., Harrison D. E. F., Pitt D. E. (1985) Effect of environment on microbial activity. Comprehensive Biotechnology. 1:253-279.
Gao H., Tan T. (2003) Fed-batch fermentation for ergosterol production. Process Biochemistry. 39:345-350
Galan B., Garcia Mendoza C., Calonje M., Novaes-Ledieu M. (1999) News & notes: production, purification, and properties of an endo-1, 3-beta-glucanase from the basidiomycete Agaricus bisporus. Curr. Microbiol. 38:190-193.
Gehrig I., Bart H. J., Anke T. (1998) Influence of morphology and rheology on the production characteristics of the basidiomycete Cyathus striatus. Biotechnol Bioeng. 59: 525-33
Geoffery G., Mercer E. I., Goad L. J. (1985) The identification of 24-methylene-24,25-dihydrolanosterol and other possible ergosterol pressure in Phycomyces blackleeaus and Agaricus campestris. Phytochemistry. 14: 457-62
Hirotani M., Hirotani S., Takayanagi H., Yoshikawa T. (1998) Blazeispirol A, an unprecedented skeleton from the Cultured mycelia of the fungus Agaricus blazei. Tetrahedron Letters. 40: 329-332
Hirotani M., Kaneko A., Asada Y., Yoshikawa T. (2000) Biosynthesis of blazeispirol A, an unprecedented skeleton from the cultured mycelia of the fungus Agaricus blazei. Tetrahedron Letters. 41:6101-6140
Hirotani M., Hirotani S., Yoshikawa T. (2001) Blazeispirol D and Z, as the actual intermediates of blazeispirol A biosynthesis from the cultured mycelia of the fungus Agaricus blazei. Tetrahedron Letters. 42:5261-5264
Ito H., Shimura K., Itoh H., Kawade M. (1997) Antitumor effects of a new polysaccharide-protein (ATOM) prepared from Agaricus blazei (Iwade strain 101) ‘Himematsutake’ and its mechanisms in Tumor-Bearing Mice. Anticancer Res. 17:277-284.
Izawa S., Lnoue Y. (2004) A screening system for antioxidants using thioredoxin-deficient yeast: discovery of thermostable antioxidant activity from Agaricus blazei Murill. Appl. Microbiol. Biotechnol. 64(4):537-542.
Kang A., Wang Y., Harvey L. M., McNeil B. (2000) Effect of air flow rate on scleroglucan synthesis by Sclerotium glucanicum in an airlift bioreactor with an internal loop. Bioprocess Engineering. 23:69-74.
Ker Y. B., Chen K. C., Chyau C. C., Chen C. C., Guo J. H., Hsieh C. L., Wang H. E., Peng C. C., Chang C. H., Peng R. Y. (2005) Antioxidant capability of polysaccharides fractionated from submerge-cultured Agaricus blazei mycelia. J Agric Food Chem 53(18):7052-7058.
Kim Y. W., Kim K. H., Choi H. J., Lee D. S. (2005) Anti-diabetic activity of β-glucans and their enzymatically hydrolyzed oligosaccharides from Agaricus blazei. Biotechnol Lett. 27:483-487
Kobayashi H., Yoshida R., Kanada Y., Fukuda Y., Yagyu T., Inagaki K., Kondo T., Kurita N., Suzuki M., Kanayama N., Terao T. (2005) Suppressing effects of daily oral supplementation of beta-glucan extracted from Agaricus blazei Murill on spontaneous and peritoneal disseminated metastasis in mouse model. J Cancer Res Clin Oncol 131(8):527-538.
Kuroiwa Y., Nishikawa A., Imazawa T., Kanki K., Kitamura Y., Umemura T., Hirose M. (2005) Lack of subchronic toxicity of an aqueous extract of Agaricus blazei Murrill in F344 rats. Food Chem Toxicol 43(7):1047-1053.
Luiz R. C., Jordao B. Q., Da-Eira A. F., Ribeiro L. R. and Mantovani M. S. (2003) Mechanism of anticlastogenicity of Agaricus blazei Murill mushroom organic extracts in wild type CHO(K1) and repair deficient (xrs5) cells by chromosome aberration and sister chromatid exchange assays. Mutation Res. 528:75-79.
Lin J. H., Yang S. S. (2006) Mycelium and polysaccharide production of Agaricus blazei Murrill by submerged fermentation. J. Microbiol. Immunol. Infect. 39:98-108.
Moradali M. F, Mostafavi H., Ghods S., Hedjaroude G. A. (2007) Immunomodulating and anticancer agents in the realm of macromycetes fungi (macrofungi), International Immunopharmacology 7:701-724.
Metz B., Kossen N. W. F. (1997) The growth of molds in the form of pellets: Literature review, Biotechnology and Bioengineering, 19:781-799.
Menoli R. C. N., Mantovani M. S., Ribeiro L. R., Gunter S., Jordão B. Q. (2001) Antimutagenic effects of the mushroom Agaricus blazei Murill extracts on V79 cells, Mutation Research 496:5-13.
Mizuno M., Minato K., Ito H., Kawade M., Terai H., Tsuchida H. (1999) Anti-tumor polysaccharide from the mycelium of liquid-cultured Agaricus blazei mill. Biochem Mol Biol Int 47(4):707-714
Mizuno T. (2002) Medicinal Properties and Clinical Effects of Culinary-Medicinal Mushroom Agaricus blazei Murill (Agaricomycatideae) (Review). International Journal of Medicinal Mushroom 4:299-312
Ohno N., Akanuma A. M., Miiura N. N., Adachi Y., Motoi M. (2001b) 1,3-β-D-glucan in the fruit bodies of Agaricus blazei. Pharm. Pharmacol Lett. 2: 87-90.
Oliveira J. M., Jordão B. Q., Ribeiro L. R., Eira A. F., Mantovani M. S. (2002) Anti-genotoxic effect of aqueous extracts of sun mushroom
(Agaricus blazei Murill lineage 99/26) in mammalian cells in vitro, Food and Chemical Toxicology 40:15-20.
Papagianni M. (2004) Fungal morphology and metabolite production in submerged mycelial process. Biotechnology Advances. 22: 189-259
Papagianni M., Mattey M. (2006) Morphological development of Aspergillus niger in submerged citric acid fermentation as a function of the spore inoculum level. Application of neural network and cluster analysis for characterization of mycelial morphology. Microbial Cell Factories. 5: 3
Peng R. Y., Ker Y. B., Chen K. C., Chyau C. C., Chen C. C., Guo J. H., Hsieh C. L., Wang H. E., Peng C. C., Chang C. C. (2005) Antioxidant capability of polysaccharides fractionated from submerge-cultured Agaricus blazei mycelia. J. Agric. Food Chem. 52:7052-7058.
Rau U., Gura E., Olszewski E., Wagner F. (1992) Enhanced glucan formation of flamentous fungi by effective mixing, oxygen limitation and fed-batch processing, Journal of Industrial Microbiology, 9:19-26.
Shiao M. S., Lee K. R., Lee J. L., Cheng T. W. (1994) Natural products and biological activities of the Chinese medicinal fungus Ganoderma lucidum. ACS Symp. Ser. 547 Food Phytochemicals for Cancer Prevention II. Washington DC: American Chemical Society. pp. 342-354.
Sinha J., Bae J. T., Park J. P., Song C. H., Yun J. W. (2001) Effect of substrate concentration on broth rheology and fungal morphology during exo-biopolymer production by Paecilomyces japonica in a batch bioreactor. Enzyme and Microbial Technology. 29: 392-99.
Sorimachi K., Ikehara Y., Maezato G., Okubo A., Yamazaki S., Akimoto K., Niwa A. (2001) Inhibition by Agaricus blazei Murill fractions of cytopathic effect induced by western equine encephalitis (WEE) virus on VERO cells in vitro. Biosci Biotechnol Biochem. 65(7):1645-1647.
Sonnletiner B., (1998) Dynamic adaptation of microbes. Journal of Biotechnology, 65:47-60.
Talorete T. P., Isoda H., Maekawa T. (2002) Agaricus blazei (class Basidiomycotina) aqueous extract enhances the expression of c-Jun protein in MCF7 cells. J. Agric. Food Chem. 50(18):5162-5166.
Takimoto H. Wakita D. Kawaguchi K., Kumazawa Y. (2004) Potentiation of cytotoxic activity in naive and tumor-bearing mice by oral administration of hot-water extracts from Agaricus brazei fruiting bodies. Biol. Pharm. Bull. 27(3):404-406
Tamerler C., Ullah M., Adlard M. W., Keshavarz T. (1998) Effect of pH on physiology of Metarhizium anisopliae for production of swainsonine. FEMS Microbiology Letters, 168, 17-23
Tucker K. G., Thomas C. R. (1993) Effect of biomass concentration and morphology on the rheological parameters of Penicillium chrysogenum fermentation broths. Trans Chem Eng. 71: 111-7
Watanabe T., Yamada T., Tanaka H., Jiang S., Mazumder T. K., Nagai S., Tsuji K. (2002) Antihypertensive effect of gamma-aminobutyric acid enriched Agaricus blazei on spontaneously hypertensive rats. Journal of the Japanese Society of Food Science and Technology 499:166–173.
Yang F. C., Huang H. C., Yang M. J. (2003) The influence of environmental conditions on the mycelial growth of Antrodia cinnamomea in submerged cultures. Enzyme and Microbial Technology. 33:395-402.
Yang F. C., Hsieh C., Chen H. M. (2003) Use of stillage grain from a rice-spirit distillery in the solid state fermentation of Ganoderma lucidum. Process Biochemistry. 39:21-26.
Ying Z., Yang S. T., (2004) Effect of pH on metabolic pathway shift in fermentation of xylose by Clostridium tyrobutyricum. Journal of Biotechnology. 110: 143-157.
Zhu Y., Yang S. T. (2004) Effect of pH on metabolic pathway shift in fermentation of xylose by Clostridium tyrobutyricum. Journal of Biotechnology. 110: 143-157.
Znidarsic P., Komel R., Pavko A. (2001) Influence of some environmental factors on Rhizopus nigricans submerged growth in the form of pellets. World Journal of Microbiology & Biotechnology. 16: 589-593.
Zou X. (2006) Fed-batch fermentation for hyperproduction of polysaccharide and ergosterol by medicinal mushroom Agaricus brasiliensis. Process Biochemistry. 41:970-974.
指導教授 徐敬衡(Chin-Hang Shu) 審核日期 2007-7-20
推文 facebook   plurk   twitter   funp   google   live   udn   HD   myshare   reddit   netvibes   friend   youpush   delicious   baidu   
網路書籤 Google bookmarks   del.icio.us   hemidemi   myshare   

若有論文相關問題,請聯絡國立中央大學圖書館推廣服務組 TEL:(03)422-7151轉57407,或E-mail聯絡  - 隱私權政策聲明